menu
    • menu

    Company profile for Appia Bio

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We collaborate across a diversity of disciplines, which is critical to developing next-generation therapies for patients. Our research and development efforts are focused on creating engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases therapeutic options and availability for patients. With our ACUA technology platform, Appia Bio leverages the biology of l...
    We collaborate across a diversity of disciplines, which is critical to developing next-generation therapies for patients. Our research and development efforts are focused on creating engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases therapeutic options and availability for patients. With our ACUA technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Appia BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    570 Westwood Plaza Los Angeles, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.appiabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/appiabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kite-Partnered Appia Shuts Down as Funding Runs Dry
    Kite-Partnered Appia Shuts Down as Funding Runs Dry

    25 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kite-partnered-appia-bio-shuts-down-reaching-clinic-after-funding-runs-dry

    FIERCE BIOTECH
    25 Aug 2025
    Share Share
    Kite inks research pact with Appia Bio to develop allogeneic cell therapies
    Kite inks research pact with Appia Bio to develop allogeneic cell therapies

    07 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=140643&sid=2

    PHARMABIZ
    07 Aug 2021
    Share Share
    Gilead's Kite inks up to $875M blood cancer pact with Appia Bio
    Gilead's Kite inks up to $875M blood cancer pact with Appia Bio

    07 Aug 2021

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/gilead-s-kite-to-pay-up-to-875m-for-blood-cancer-pact-appia-bio

    Kyle LaHucik FIERCEBIOTECH
    07 Aug 2021
    Share Share
    Kite and Appia Bio to develop allogeneic cell therapies for blood cancer
    Kite and Appia Bio to develop allogeneic cell therapies for blood cancer

    06 Aug 2021

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/kite-appia-bio-cancer/

    PHARMACEUTICAL TECHNOLOGY
    06 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search